Quidel Gets FDA OK for Flu Assay on Cepheid System
March 22, 2012
Quidel Gets FDA OK for Flu Assay on Cepheid System
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- In Cepheid v. Roche IP Suit, Court Delays Hearing on One Patent, Dismisses Second Patent from Case
January 18, 2013 / GenomeWeb Daily News - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News - Quidel Q2 Revenues up 12 Percent; Discloses New Life Tech Deal for PCR Assays
July 26, 2012 / GenomeWeb Daily News - Unitaid Provides $30M to Lower Cost of Cepheid TB Test in Developing World
June 14, 2012 / GenomeWeb Daily News - Quidel Obtains CE Mark for AmpliVue C. Difficile, Company's First Handheld MDx Test
March 29, 2012 / PCR Insider